Haemonetics Corporation · NYSE:HAE
Vanguard Capital Management LLC reported a 5.26% stake in Haemonetics Corporation (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 30, 2026
Vanguard Capital Management LLC reported a 5.26% stake in Haemonetics Corporation, 2,445,817 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).
- Stake
- 5.26%
- Shares
- 2,445,817
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.26% | 2,445,817 |
Source
Related
- Haemonetics Corporation
- Vanguard Capital Management LLC
- Haemonetics Corporation shareholders
- Schedule 13G/A · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Abernathy Robert E · Jul 28, 2026
- Form 4 · Madaus Martin D · Jul 28, 2026
- Form 4 · Zane Ellen M · Jul 28, 2026
- Form 4 · Pomeroy Claire · Jul 28, 2026